Hello, everyone, and how are you today? A bright sun is hovering over the Pharmalot corporate campus this morning, where we are busy organizing our priorities and already planning for next week. Nothing like trying to get a head start, yes? This calls, of course, for a cup of stimulation, so please join us. Meanwhile, here are a few tidbits from around the world. Hope your day goes well...
Lilly And Boehringer Diabetes Med Gets European OK (Associated Press)
United Therapeutics Misses Study Goal (Bloomberg News)
Alexa Life Sciences Rejects Offer From Paladin Labs (Pharma Times)
Charles River Unifies Research And Preclinical Services Units (Contract Pharma)
EDITOR'S NOTE: Please check this post for updates throughout the morning